2C-H

2C-H

Substituted phenethylamines · Psychedelic, Stimulants

5 dangerous interactions — combining 2C-H with certain substances may be life-threatening.

Psychedelic, Stimulants(Substituted phenethylamines)

2C-H (2,5-dimethoxyphenethylamine) is the unsubstituted parent compound of the 2C family — lacking any substituent at the 4-position of the phenyl ring that characterizes all the named members of the series. It was documented by Alexander Shulgin in PiHKAL (1991), though its primary interest is chemical and historical rather than experiential. 2C-H's main practical significance in Shulgin's research program was as the key chemical precursor for synthesizing the rest of the 2C family; the 4-position of the unsubstituted ring could be selectively functionalized to introduce bromine (yielding 2C-B), iodine (2C-I), chlorine (2C-C), and other groups.

As a psychoactive compound, 2C-H is expected to be extremely weak — the absence of a 4-substituent substantially reduces 5-HT2A receptor affinity, meaning doses that would be required for any significant psychedelic effect would be impractically high and would carry meaningful MAO liability. As an unprotected para-hydrogen compound, 2C-H is susceptible to rapid oxidative metabolism by monoamine oxidase enzymes, which would likely destroy most of the absorbed compound before it could produce central effects.

The compound has occasional historical appearances as an adulterant or unintended degradation product rather than as a primary substance of interest. In the context of phenethylamine pharmacology, it serves as the negative control — demonstrating that the 4-position substituent is not merely cosmetic but is pharmacologically essential to the psychedelic activity of the 2C family.

How It Feels

The experience of 2C-H, to the extent that one can speak of an experience at all, is defined by its remarkable subtlety. At common oral doses, the compound sits at or just below the threshold of psychoactivity, producing effects so faint that distinguishing them from placebo, expectation, or the ordinary fluctuations of consciousness becomes a genuine challenge. What exists is not so much a trip as a whisper of one, a suggestion that something has changed without any clear evidence of what that something is.

In the first hour after ingestion, there may be a slight warmth in the abdomen and a barely perceptible quickening of attention. Colors might appear fractionally more vivid, but not in any way that could be confidently attributed to the substance rather than to the act of looking more carefully. The mind feels nominally sharper, as though focus has been gently polished, but the effect is so modest that it would be unremarkable on any ordinary day. There is no body load to speak of, no nausea, no jaw tension, no stimulation. The body continues its usual business largely undisturbed.

At what would theoretically be the peak, around ninety minutes to two hours in, the most commonly reported effect is a mild enhancement of sensory appreciation. Music may sound slightly more detailed. Textures may feel marginally more interesting under the fingertips. There is perhaps a gentle elevation of mood, a quiet positivity that colors the experience without transforming it. If visual effects exist at all, they are confined to the subtlest possible enhancement of color and contrast, visible only to those actively searching for them.

The experience, such as it is, fades over the next two to three hours without ceremony. There is no comedown in any meaningful sense because there was so little to come down from. The body feels normal. The mind feels normal. The most lasting impression is often one of curiosity about what might have happened at higher doses, though 2C-H's pharmacological profile suggests that increasing the dose would likely produce more side effects before producing genuinely interesting psychedelic effects. Its primary significance is as a chemical scaffold, a structural parent from which more active members of the 2C family are derived, rather than as a psychoactive experience in its own right.

Interactions

Substance	Status	Note
Atropa belladonna	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Datura	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Diphenhydramine	Dangerous	Extreme cardiovascular strain from anticholinergic and stimulant effects combined
Harmala alkaloid	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Peganum harmala	Dangerous	Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
1,3-Butanediol	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
25E-NBOH	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-2	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-21	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
2C-T-7	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
3-FMA	Caution	Increased cardiovascular strain and neurotoxicity risk
4-MMC	Caution	Increased cardiovascular strain and neurotoxicity risk
8-Chlorotheophylline	Caution	Increased cardiovascular strain and neurotoxicity risk
Adrafinil	Caution	Increased cardiovascular strain and neurotoxicity risk
Allylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Ayahuasca	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Benzydamine	Caution	Increased cardiovascular strain and neurotoxicity risk
Bromantane	Caution	Increased cardiovascular strain and neurotoxicity risk
Cake	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Deschloroetizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Desomorphine	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
DET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Dichloropane	Caution	Increased cardiovascular strain and neurotoxicity risk
Diclazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
DiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DOM	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
DPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Efavirenz	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Ephedrine	Caution	Increased cardiovascular strain and neurotoxicity risk
EPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Eszopiclone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Etizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flubromazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Flunitrazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Gaboxadol	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Hexedrone	Caution	Increased cardiovascular strain and neurotoxicity risk
Ibogaine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Lorazepam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Mephenaqualone	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MET	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methallylescaline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increased cardiovascular strain and neurotoxicity risk
Metizolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Midazolam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
MiPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
MPT	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Naloxone	Caution	Stimulants mask opioid sedation, increasing overdose risk when the stimulant wears off
Nicotine	Caution	Increased cardiovascular strain and neurotoxicity risk
Nifoxipam	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Oxiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Pentobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenobarbital	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Phenylpiracetam	Caution	Increased cardiovascular strain and neurotoxicity risk
Psilocybin Mushrooms	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increased cardiovascular strain and neurotoxicity risk
SAMe	Caution	Masks the effects of each drug; risk of overdosing when one wears off before the other
Cannabis	Uncertain	—
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined

Toxicity & Safety

Unknown Profile

No formal human toxicological data exists for 2C-H. Its minimal psychoactive profile means there is very little documented human use, and therefore almost no safety data of any kind.

MAO Metabolism Concerns

The MAO vulnerability that limits 2C-H's psychedelic activity does not reduce cardiovascular risk — peripheral phenethylamine activity remains possible, and in combination with MAOIs, even a weak peripheral sympathomimetic can cause hypertensive crisis.

Stimulant Class Risks

2C-H carries the baseline cardiovascular risks of any substituted phenethylamine: potential for elevated heart rate, blood pressure increase, and sympathetic nervous system activation. These apply regardless of whether psychedelic effects are prominent.

Drug Interactions

MAOIs: Potentially dangerous due to peripheral sympathomimetic activity; absolutely contraindicated
Other stimulants: Additive cardiovascular risk

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from 2C-H alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3-5 days
Zero	7-10 days

Dosage

Duration

How It Feels

Subjective Effects

Physical Effects

Physical(3)

Cognitive & Perceptual Effects

Cognitive(1)

Pharmacology

Mechanism of Action

MAO Vulnerability

Binding Data

Chemical Precursor Role

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Role in Shulgin's Research Program

As a Precursor

Harm Reduction

This Compound Has No Known Beneficial Use

If Encountered Unexpectedly

MAOI Contraindication

Toxicity & Safety

Unknown Profile

MAO Metabolism Concerns

Stimulant Class Risks

Drug Interactions

Addiction Potential

Overdose Information

Dangerous Interactions

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (4)

See Also

References (5)

Frequently Asked Questions